+ All Categories
Home > Documents > Group4 Infection & Patient Visibility

Group4 Infection & Patient Visibility

Date post: 22-Jan-2016
Category:
Upload: poppy
View: 33 times
Download: 0 times
Share this document with a friend
Description:
Group4 Infection & Patient Visibility. Infection Case Study. Hip hemiarthroplasty after displaced femoral neck fracture: a survivorship analysis Femoral neck fracture – broken knee joint - PowerPoint PPT Presentation
Popular Tags:
11
1
Transcript
Page 1: Group4  Infection &  Patient Visibility

1

Page 2: Group4  Infection &  Patient Visibility

Hip hemiarthroplasty after displaced femoral neck fracture: a survivorship analysis

• Femoral neck fracture – broken knee joint • Total Hip Arthroplasty – Yes….better results for patients than internal fixation and hemiarthroplasty.• Some Results for age group 60 + differ from this: “0-35 % dislocation cases” – quite highREASON ? Major one is comorbidities!

2

Page 3: Group4  Infection &  Patient Visibility

Biomarkers as a Tool for Management of Immunosuppression in Transplant Patients

•Immuno-suppressive drugs•Without immunosuppression therapy, transplatation surgery could be fatal.•Therapeutic drug monitoring – DOES NOT reflect adverse effects to immune cells.•Pharmacodynamic monitoring (biomarkers)

3

Page 4: Group4  Infection &  Patient Visibility

Problem of infection in the ICU

•Infections possible - ventilator-associated pneumonia, catheter-associated urinary tract infection, catheter-related bloodstream infection•Need to be attentive to horizontal infection

and use proper antibiotics for multi-resistant bacteria like MRSA.

4

Page 5: Group4  Infection &  Patient Visibility

Managing infection in the critical care unit: how can infection control make the ICU safe?

Infection Control in the ICU

Device Related Nosocomial Infection In ICU

5

Page 6: Group4  Infection &  Patient Visibility

6

Ventilator Associated Pneumonia

Antibiotic Resistance Pathogens

Catheter-related Infections

Page 7: Group4  Infection &  Patient Visibility

Modifiable◦ Frequency of ventilator

circuit changes◦ Antibiotic usage

Nonmodifiable◦ Patient age and gender◦ Severity of illness◦ Coma

7

Bronchoscopic techniques

Nonbronchoscopic techniques

Balance between initial antibiotic and overuse

Risk Factors Prevention

Page 8: Group4  Infection &  Patient Visibility

Decrease Infection in Neonatal Intensive Care Unit

8

Page 9: Group4  Infection &  Patient Visibility

Long-Term Acute Care Hospital

9

Page 10: Group4  Infection &  Patient Visibility

  VAP rate per 1,000 device days

CR-BSI rate per 1,000 device days

Year 1997 2004 2002 2004

Medical ICU 29 18 8.2 3.4

Surgical ICU Similar declines  10.5 4.5

Burn Center Similar declines  9.5 1.85

10

Bundle Methodology

VAP: Ventilator-Associated PneumoniaCR-BSIs: Catheter-Related Bloodstream Infections

Pursuing perfection in fighting with VAP and CR-BSIs in ICU

Page 11: Group4  Infection &  Patient Visibility

11


Recommended